109 related articles for article (PubMed ID: 28830458)
1. Role of MEK partner-1 in cancer stemness through MEK/ERK pathway in cancerous neural stem cells, expressing EGFRviii.
Kwon SJ; Kwon OS; Kim KT; Go YH; Yu SI; Lee BH; Miyoshi H; Oh E; Cho SJ; Cha HJ
Mol Cancer; 2017 Aug; 16(1):140. PubMed ID: 28830458
[TBL] [Abstract][Full Text] [Related]
2. Saccharina japonica Extract Suppresses Stemness of Glioma Stem Cells by Degrading Epidermal Growth Factor Receptor/Epidermal Growth Factor Receptor Variant III.
Kim SY; Kim JY; Shin WS; Lee SJ; Chi SG; Lee JY; Park MJ
J Med Food; 2018 May; 21(5):496-505. PubMed ID: 29648968
[TBL] [Abstract][Full Text] [Related]
3. DMRTA2 supports glioma stem-cell mediated neovascularization in glioblastoma.
Maleszewska M; Wojnicki K; Mieczkowski J; Król SK; Jacek K; Śmiech M; Kocyk M; Ciechomska IA; Bujko M; Siedlecki J; Kotulska K; Grajkowska W; Zawadzka M; Kaminska B
Cell Death Dis; 2024 Mar; 15(3):228. PubMed ID: 38509074
[TBL] [Abstract][Full Text] [Related]
4. Stratification of glioma based on stemness scores in bulk and single-cell transcriptomes.
Abdelrahman Z; Abdelatty A; Luo J; McKnight AJ; Wang X
Comput Biol Med; 2024 Jun; 175():108304. PubMed ID: 38663352
[TBL] [Abstract][Full Text] [Related]
5. Cell Populations Expressing Stemness-Associated Markers in Vascular Anomalies.
Kilmister EJ; Hansen L; Davis PF; Hall SRR; Tan ST
Front Surg; 2020; 7():610758. PubMed ID: 33634164
[TBL] [Abstract][Full Text] [Related]
6. StemnesScoRe: an R package to estimate the stemness of glioma cancer cells at single-cell resolution.
Koçhan N; Oktay Y; Karakülah G
Turk J Biol; 2023; 47(6):383-392. PubMed ID: 38681778
[TBL] [Abstract][Full Text] [Related]
7. Lack of Constitutively Active DNA Repair Sensitizes Glioblastomas to Akt Inhibition and Induces Synthetic Lethality with Radiation Treatment in a p53-Dependent Manner.
Palanichamy K; Patel D; Jacob JR; Litzenberg KT; Gordon N; Acus K; Noda SE; Chakravarti A
Mol Cancer Ther; 2018 Feb; 17(2):336-346. PubMed ID: 28838997
[TBL] [Abstract][Full Text] [Related]
8. Optimization of Glioblastoma Mouse Orthotopic Xenograft Models for Translational Research.
Irtenkauf SM; Sobiechowski S; Hasselbach LA; Nelson KK; Transou AD; Carlton ET; Mikkelsen T; deCarvalho AC
Comp Med; 2017 Aug; 67(4):300-314. PubMed ID: 28830577
[TBL] [Abstract][Full Text] [Related]
9. Cellular heterogeneity contributes to subtype-specific expression of ZEB1 in human glioblastoma.
Euskirchen P; Radke J; Schmidt MS; Schulze Heuling E; Kadikowski E; Maricos M; Knab F; Grittner U; Zerbe N; Czabanka M; Dieterich C; Miletic H; Mørk S; Koch A; Endres M; Harms C
PLoS One; 2017; 12(9):e0185376. PubMed ID: 28945795
[TBL] [Abstract][Full Text] [Related]
10. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
Weller M; Butowski N; Tran DD; Recht LD; Lim M; Hirte H; Ashby L; Mechtler L; Goldlust SA; Iwamoto F; Drappatz J; O'Rourke DM; Wong M; Hamilton MG; Finocchiaro G; Perry J; Wick W; Green J; He Y; Turner CD; Yellin MJ; Keler T; Davis TA; Stupp R; Sampson JH;
Lancet Oncol; 2017 Oct; 18(10):1373-1385. PubMed ID: 28844499
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers and therapeutic advances in glioblastoma multiforme.
Sasmita AO; Wong YP; Ling APK
Asia Pac J Clin Oncol; 2018 Feb; 14(1):40-51. PubMed ID: 28840962
[TBL] [Abstract][Full Text] [Related]
12. PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.
Guadagno E; Vitiello M; Francesca P; Calì G; Caponnetto F; Cesselli D; Camorani S; Borrelli G; Califano M; Cappabianca P; Arra C; Crescenzi E; Cerchia L; De Caro MLDB; Fedele M
Oncotarget; 2017 Aug; 8(35):59282-59300. PubMed ID: 28938636
[TBL] [Abstract][Full Text] [Related]
13. A novel mechanism of ERK1/2 regulation in smooth muscle involving acetylation of the ERK1/2 scaffold IQGAP1.
Vetterkind S; Lin QQ; Morgan KG
Sci Rep; 2017 Aug; 7(1):9302. PubMed ID: 28839270
[TBL] [Abstract][Full Text] [Related]
14. Atypical cyclin P regulates cancer cell stemness through activation of the WNT pathway.
Sánchez-Botet A; Quandt E; Masip N; Escribá R; Novellasdemunt L; Gasa L; Li VSW; Raya Á; Clotet J; Ribeiro MPC
Cell Oncol (Dordr); 2021 Dec; 44(6):1273-1286. PubMed ID: 34604945
[TBL] [Abstract][Full Text] [Related]
15. ERK Phosphorylation Regulates the Aml1/Runx1 Splice Variants and the TRP Channels Expression during the Differentiation of Glioma Stem Cell Lines.
Santoni G; Nabissi M; Amantini C; Santoni M; Ricci-Vitiani L; Pallini R; Maggi F; Morelli MB
Cells; 2021 Aug; 10(8):. PubMed ID: 34440820
[TBL] [Abstract][Full Text] [Related]
16. Circ_0075829 facilitates the progression of pancreatic carcinoma by sponging miR-1287-5p and activating LAMTOR3 signalling.
Zhang X; Xue C; Cui X; Zhou Z; Fu Y; Yin X; Wu S; Gong Y; Liu Y; Zhu C; Qin X
J Cell Mol Med; 2020 Dec; 24(24):14596-14607. PubMed ID: 33184989
[TBL] [Abstract][Full Text] [Related]
17. ERK-mediated negative feedback regulation of oncogenic EGFRvIII in glioblastoma cells.
Haryuni RD; Tanaka T; Zhou Y; Yokoyama S; Sakurai H
Oncol Lett; 2020 Sep; 20(3):2477-2482. PubMed ID: 32782566
[TBL] [Abstract][Full Text] [Related]
18. Gaps and Doubts in Search to Recognize Glioblastoma Cellular Origin and Tumor Initiating Cells.
Wlodarczyk A; Grot D; Stoczynska-Fidelus E; Rieske P
J Oncol; 2020; 2020():6783627. PubMed ID: 32774372
[TBL] [Abstract][Full Text] [Related]
19. Demethoxycurcumin analogue DMC-BH inhibits orthotopic growth of glioma stem cells by targeting JNK/ERK signaling.
Shi L; Sun G; Zhu H
Aging (Albany NY); 2020 Jul; 12(14):14718-14735. PubMed ID: 32710727
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in
Liu HW; Lee PM; Bamodu OA; Su YK; Fong IH; Yeh CT; Chien MH; Kan IH; Lin CM
Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31783691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
